Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its CORIOGRAPH Pre-Op Planning and Modeling Services for total shoulder arthroplasty, now available in the United States. This innovative software offers image-based planning capabilities that enable surgeons to create a patient-specific plan for shoulder replacement procedures by using enhanced clinical decision-making through advanced biomechanical simulation that accounts for scapulothoracic motion.1-6
The first procedures using CORIOGRAPH Services for Shoulder were recently completed by Dr. Christopher Klifto, Shoulder Surgeon at Duke University. He commented, “CORIOGRAPH Services help choose the proper components to help ensure the best plan for my patients. Cases are precisely planned by dedicated planning engineers according to surgeon preferences and can be easily modified by the surgeon using the web planner as a final check when needed. The Activity of Daily Living function has the potential to optimize range of motion based on patient needs and is unique in the shoulder arthroplasty space. CORIOGRAPH Services has given me greater confidence to plan my cases and provide optimal care for my patients.”
Key capabilities of CORIOGRAPH Pre-Op Planning and Modeling Services for total shoulder arthroplasty include:
- Supports 3D CT-based planning, giving surgeons the ability to visualize implant options and optimize component positioning and sizing with patient-specific anatomical modeling.1-6
- Designed to minimize impingement through personalized service and surgeon planning tools.1-6
- Range-of-motion and impingement simulation, designed to help surgeons optimize implant placement based on patient-specific shoulder kinematics through real-time modeling of Activities of Daily Living that account for scapulothoracic motion.1-6
- Seamless integration with Smith+Nephew’s full portfolio of AETOS◊ Shoulder System implant solutions.
The AETOS Shoulder System is purposefully designed to work as a cohesive solution, enhancing the surgical experience through streamlined* intraoperative flexibility.7-9 With fewer instruments for a primary Meta Stem procedure†9 and fewer steps when converting from anatomic to reverse,†9 the AETOS Shoulder System is designed to support a more efficient operating room environment.9 When paired with CORIOGRAPH Services, surgeons can plan their cases in advance, empowering confident, real-time decision making and an efficient overall workflow.
“With the addition of shoulder pre-op planning to the CORIOGRAPH Services platform, we are completing our vision of truly personalized orthopaedic care across hip, knee, and shoulder replacements,” said Mayank Shandil, Global SVP of Reconstruction and Robotics Marketing for Smith+Nephew. “As we continue to invest in data-driven and patient-centric tools, surgeons are better equipped to deliver a personalized plan for each patient every time.”
To learn more about CORIOGRAPH Pre-Op Planning and Modeling Services for total shoulder arthroplasty, please visit here.
- ends –
Media Enquiries
Dave Snyder +1 (978) 749-1440
Smith+Nephew david.snyder@smith-nephew.com
References
- Smith+Nephew 2025. 10152295 REVA. Shoulder Modeler TR - Session Management & Notifications/Warnings/Errors
- Smith+Nephew 2025. 10152290 REVA. Shoulder Modeler TR - CORIOGRAPH Plan Page
- Smith+Nephew 2025. 10152289 REVA. Shoulder Modeler TR - General Features
- Smith+Nephew 2025. 10152294 REVA. Shoulder Modeler TR - Report Page
- Smith+Nephew 2025. 10152293 REVA. Shoulder Modeler TR - Implant Planning
- Smith+Nephew 2025. 10152196 REVB. CORIOGRAPH Modeler Unit Test Execution Report
- Smith+Nephew 2023. AETOS Inlay Design Features. Internal Report. ER-04-0990-0017.
- Smith+Nephew 2024. AETOS Short Stem Stability Report. Internal Report. ER-04-0990-0008 REV AC
- Smith+Nephew 2023. AETOS Instruments & Trays. Internal Report. ER-04-0990-0020 REV B
*Intraoperative flexibility via an anatomic metaphyseal shape and neck cut that is universal to both stemless and Meta stem, and streamlined instrumentation that allows for ease of convertibility from stemless to Meta Stem and TSA to RSA
†Compared to a competitive shoulder system
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 17,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $5.8 billion in 2024. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.
◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.